Astrana Health (NASDAQ:ASTH) Reaches New 12-Month Low – Should You Sell?

Astrana Health, Inc. (NASDAQ:ASTH)’s share price hit a new 52-week low during trading on Monday . The stock traded as low as $31.20 and last traded at $31.35, with a volume of 194714 shares. The stock had previously closed at $32.18.

Analyst Ratings Changes

A number of research firms recently weighed in on ASTH. TD Cowen started coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price target on the stock. KeyCorp assumed coverage on shares of Astrana Health in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Robert W. Baird upped their target price on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. Finally, BTIG Research boosted their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Astrana Health currently has a consensus rating of “Moderate Buy” and an average target price of $65.17.

Astrana Health Trading Up 2.1 %

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The stock has a 50-day moving average price of $40.97 and a 200-day moving average price of $47.24. The stock has a market cap of $1.78 billion, a P/E ratio of 24.35, a P/E/G ratio of 1.80 and a beta of 1.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.33. The company had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same period in the previous year, the firm posted $0.47 EPS. On average, equities research analysts expect that Astrana Health, Inc. will post 1.16 EPS for the current year.

Institutional Trading of Astrana Health

Institutional investors have recently added to or reduced their stakes in the business. GAMMA Investing LLC purchased a new position in shares of Astrana Health in the third quarter worth $34,000. Nisa Investment Advisors LLC purchased a new position in shares of Astrana Health in the third quarter valued at about $35,000. KBC Group NV bought a new position in shares of Astrana Health during the third quarter valued at about $70,000. Quarry LP bought a new position in shares of Astrana Health during the third quarter valued at about $77,000. Finally, Quest Partners LLC bought a new stake in shares of Astrana Health in the third quarter worth about $133,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.